First New York Securities’s Biogen BIIB Stock Holding History

First New York Securities’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,000	Closed	-$422K	–	448
2015 Q1	$422K	Buy	+1,000	New	+$394K	0.42%	33

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

First New York Securities's BIIB Position: Q2 2015 in Review

First New York Securities sold out of Biogen (BIIB) in Q2 2015, closing a stake of 1,000 shares — an estimated $422K sold.

First New York Securities first reported a position in BIIB in Q1 2015 and held it in 1 quarter. The position peaked at $422K in Q1 2015. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

First New York Securities reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
First New York Securities sold 1,000 Biogen shares in Q2 2015, an estimated $422K.
First New York Securities first reported a position in Biogen in Q1 2015 and held it in 1 quarter.
First New York Securities's Biogen position peaked at $422K in Q1 2015.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on First New York Securities's 13F filing for Q2 2015, filed 30 Jul 2015.